EcoR1 Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
10
- Investments
-
137
- Portfolio
-
38
- Exits
-
72
EcoR1 Capital General Information
Company Description
Founded in 2012, EcoR1 Capital is a venture capital firm based in San Francisco, California. The firm seeks to invest in the healthcare, life science & oncology sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.ecor1cap.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 357 Tehama Street
- Floor 3
- San Francisco, CA 94103
- United States
EcoR1 Capital Investments (137)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Neurogene | 05-Nov-2024 | PIPE | Drug Discovery | Generating Revenue | ||
| Aktis Oncology | 20-Sep-2024 | Drug Discovery | Pre-Clinical Trials | |||
| AnaptysBio | 13-Aug-2024 | Biotechnology | Generating Revenue/Not Profitable | |||
| Cargo Therapeutics | 12-Aug-2024 | Drug Discovery | Generating Revenue | |||
| Scorpion Therapeutics | 16-Jul-2024 | Drug Discovery | Generating Revenue | |||
| Bicycle Therapeutics | 28-May-2024 | Drug Discovery | Generating Revenue | |||
| Ajax Therapeutics | 13-May-2024 | Drug Discovery | Generating Revenue | |||
| Attovia | 01-May-2024 | Biotechnology | Pre-Clinical Trials | |||
| BridgeBio Oncology Therapeutics | 30-Apr-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| Crinetics Pharmaceuticals | 01-Mar-2024 | PIPE | Drug Discovery | Generating Revenue/Not Profitable |
EcoR1 Capital Exits (72)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Gritstone bio | 10-Oct-2024 | Bankruptcy: Admin/Reorg | |
| Crinetics Pharmaceuticals | 08-Oct-2024 | ||
| Cerevel Therapeutics | 01-Aug-2024 | ||
| Artiva | 19-Jul-2024 | ||
| Abeona Therapeutics | 03-May-2024 | ||
| Janux Therapeutics | 29-Feb-2024 | ||
| Kymera Therapeutics | 05-Jan-2024 | ||
| Neurogene | 19-Dec-2023 | ||
| Syros Pharmaceuticals | 19-Dec-2023 | Public Investment 2nd Offering | |
| Amagma Therapeutics | 26-Nov-2023 | Merger/Acquisition |
EcoR1 Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
EcoR1 Capital Co-Investors (173)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Logos Capital | 7 |
|
|
||
| Janus Henderson Investors |
|
|
|||
| RA Capital Management |
|
|
|||
| Samsara BioCapital |
|
|
|||
| Wellington Management |
|
|
EcoR1 Capital FAQs
-
What is EcoR1 Capital?
Founded in 2012, EcoR1 Capital is a venture capital firm based in San Francisco, California.
-
When was EcoR1 Capital founded?
EcoR1 Capital was founded in 2013.
-
Where is EcoR1 Capital headquartered?
EcoR1 Capital is headquartered in San Francisco, CA.
-
What is EcoR1 Capital's total asset value?
EcoR1 Capital has around in total assets under management.
-
How many investments has EcoR1 Capital made?
EcoR1 Capital has made 137 investments.
-
What has EcoR1 Capital invested in?
EcoR1 Capital has made numerous investments in companies like Neurogene, Aktis Oncology, and AnaptysBio within the Drug Discovery and Biotechnology industries.
-
What has EcoR1 Capital invested in recently?
EcoR1 Capital's latest investment was on 05-Nov-2024 in Neurogene, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
